Your browser doesn't support javascript.
An investigation of a hundred COVID-19 cases and close contacts in Ethiopia, May to June, 2020: A prospective case-ascertained study.
Watare, Shambel Habebe; Alemu, Mikias Alayu; Tayachew, Adamu; Yohannes, Negussie; Gizachew, Lehageru; Kebede, Adisu; Tessema, Asdesach; Kassa, Wubayehu; Biru, Mengistu; Teferi, Mikias; Wendrad, Naod; Eshetu, Kirubel; Teka, Gizaw; Yimer, Habtamu; Ebrahim, Faiqa; Mulugeta, Dagnachew; Mirkuze, Alemnesh; Abdela, Saro; Emmanuel, Musa; Hassen, Abdulhafiz; Wosen, Mesfin; Hussen, Mukemil; Fufa, Yaregal; Tolera, Getachew; Assefa, Zewdu; Abayneh, Aschalew; Abate, Ebba.
  • Watare SH; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Alemu MA; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tayachew A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Yohannes N; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Gizachew L; Ministry of Health, Addis Ababa, Ethiopia.
  • Kebede A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tessema A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Kassa W; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Biru M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Teferi M; Ministry of Health, Addis Ababa, Ethiopia.
  • Wendrad N; Ministry of Health, Addis Ababa, Ethiopia.
  • Eshetu K; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Teka G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Yimer H; Ministry of Health, Addis Ababa, Ethiopia.
  • Ebrahim F; World Health Organization Country Office, Addis Ababa, Ethiopia.
  • Mulugeta D; World Health Organization Country Office, Addis Ababa, Ethiopia.
  • Mirkuze A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Abdela S; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Emmanuel M; World Health Organization Regional Office for Africa, Brazzaville, Congo.
  • Hassen A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Wosen M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Hussen M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Fufa Y; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tolera G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Assefa Z; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Abayneh A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Abate E; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
PLoS One ; 17(10): e0275596, 2022.
Article in English | MEDLINE | ID: covidwho-2079747
ABSTRACT

BACKGROUND:

Corona Virus Disease 2019 is a novel respiratory disease commonly transmitted through respiratory droplets. The disease has currently expanded all over the world with differing epidemiologic trajectories. This investigation was conducted to determine the basic clinical and epidemiological characteristics of the disease in Ethiopia.

METHODS:

A prospective case-ascertained study of laboratory-confirmed COVID-19 cases and their close contacts were conducted. The study included 100 COVID-19 laboratory-confirmed cases reported from May 15, 2020 to June 15, 2020 and 300 close contacts. Epidemiological and clinical information were collected using the WHO standard data collection tool developed first-few cases and contacts investigation. Nasopharyngeal and Oropharyngeal samples were collected by using polystyrene tipped swab and transported to the laboratory by viral transport media maintaining an optimal temperature. Clinical and epidemiological parameters were calculated in terms of ratios, proportions, and rates with 95% CI.

RESULT:

A total of 400 participants were investigated, 100 confirmed COVID-19 cases and 300 close contacts of the cases. The symptomatic proportion of cases was 23% (23) (95% CI 15.2%-32.5%), the proportion of cases required hospitalization were 8% (8) (95%CI 3.5%-15.2%) and 2% (95%CI 0.24% - 7.04%) required mechanical ventilation. The secondary infection rate, secondary clinical attack rate, median incubation period and median serial interval were 42% (126) (95% CI 36.4%-47.8%), 11.7% (35) (95% CI 8.3%-15.9%), 7 days (IQR 4-13.8) and 11 days (IQR 8-11.8) respectively. The basic reproduction number (RO) was 1.26 (95% CI 1.0-1.5).

CONCLUSION:

The proportion of asymptomatic infection, as well as secondary infection rate among close contacts, are higher compared to other studies. The long serial interval and low basic reproduction number might contribute to the observed slow progression of the pandemic, which gives a wide window of opportunities and time to control the spread. Testing, prevention, and control measures should be intensified.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coinfection / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Africa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0275596

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Coinfection / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Africa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0275596